EMILY ETHERIDGE: Open Payments
NPI 1770258287 · BAILEYTON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$291 in 15 payments from 6 companies in 2025. Trend: 2023 $760 · 2024 $139 · 2025 $291
Food & beverage: $291
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $188 |
| TOLMAR, INC. | 1 | $30 |
| Antares Pharma, Inc. | 1 | $26 |
| Novo Nordisk Inc | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Atland Pharmaceuticals, LLC | 1 | $13 |
Products named: VRAYLAR, JATENZO, XYOSTED, Ozempic, TRELEGY ELLIPTA, ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE.
Industry payments across AL — which companies pay providers there.
